160 related articles for article (PubMed ID: 1363382)
1. Serum interleukin-2 and soluble interleukin-2 receptor in renal transplant recipients.
Lee PH; Chung YC; Hu RH; Huang MT; Chao SH; Lee CJ; Lee CS
J Formos Med Assoc; 1992 Sep; 91(9):844-8. PubMed ID: 1363382
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Schroeder TJ; Helling T; McKenna RM; Rush D; Jeffrey JR; Brewer B; Martin LA; Traylor D; Fisher RA; First MR
Transplantation; 1992 Jan; 53(1):34-40. PubMed ID: 1733082
[TBL] [Abstract][Full Text] [Related]
3. [A study on serum soluble interleukin-2 receptor level in the diagnosis of acute rejection in renal transplantation].
Lu J; Tian J; Zhang J
Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):371-3. PubMed ID: 8582181
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
Mehta R; Shah G; Adler W; Kittur D
Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
[TBL] [Abstract][Full Text] [Related]
5. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
Gupta RK; Jain M; Sharma RK
Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
[TBL] [Abstract][Full Text] [Related]
6. Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction.
Casiraghi F; Ruggenenti P; Noris M; Locatelli G; Perico N; Perna A; Remuzzi G
Transplantation; 1997 May; 63(10):1508-14. PubMed ID: 9175818
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating concentrations of interleukin 2 receptor during rejection episodes in heart- or kidney-transplant recipients.
Zucchelli GC; Clerico A; De Maria R; Carmellini M; Di Stefano R; Masini S; Pilo A; Donato L
Clin Chem; 1990 Dec; 36(12):2106-9. PubMed ID: 2253354
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patients.
De Maria R; Zucchelli GC; Clerico A; Carmellini M; Di Stefano R; Masini S; Caroli A; Mian M; Bertelli A
Int J Tissue React; 1989; 11(5):261-5. PubMed ID: 2699610
[TBL] [Abstract][Full Text] [Related]
10. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.
Young JB; Windsor NT; Smart FW; Kleiman NS; Weilbaecher DG; Noon GP; Nelson DL; Lawrence EC
Transplantation; 1991 Mar; 51(3):636-41. PubMed ID: 2006520
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children.
García-Roca P; Vargas YA; Fuentes Y; Hernández AM; Ortiz L; Valverde S; Velásquez-Jones L; Romero-Navarro B; Ramón-Garcia G; Medeiros M
Pediatr Transplant; 2012 May; 16(3):274-9. PubMed ID: 22309031
[TBL] [Abstract][Full Text] [Related]
12. An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection.
Bock GH; Neu L; Long C; Patterson LT; Korb S; Gelpi J; Nelson DL
Am J Kidney Dis; 1994 Mar; 23(3):421-6. PubMed ID: 8128944
[TBL] [Abstract][Full Text] [Related]
13. A critical analysis of soluble interleukin-2 receptor levels in kidney allograft recipients.
Kaden J; Schütze B; May G
Transpl Int; 1996; 9 Suppl 1():S63-7. PubMed ID: 8959793
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the soluble interleukin 2 receptor level may determine the optimal time for cystoscopically-directed biopsy in pancreaticoduodenal allograft recipients.
Perkins JD; Munn SR; Barr D; Ferguson DC; Carpenter HA
Transplantation; 1990 Feb; 49(2):363-6. PubMed ID: 2154872
[TBL] [Abstract][Full Text] [Related]
15. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.
Yoshimura N; Oka T; Kahan BD
Transplantation; 1991 Jan; 51(1):172-6. PubMed ID: 1987687
[TBL] [Abstract][Full Text] [Related]
16. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic monitoring of sIL-2R, IL-2 and IL-6 levels of serum after double-hand transplantation].
Xiang D; Pei G; Qiu Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 May; 18(3):232-5. PubMed ID: 15211844
[TBL] [Abstract][Full Text] [Related]
18. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
19. Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients.
Simpson MA; Madras PN; Cornaby AJ; Etienne T; Dempsey RA; Clowes GH; Monaco AP
Transplantation; 1989 Feb; 47(2):218-23. PubMed ID: 2645701
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation.
Lawrence EC; Holland VA; Young JB; Windsor NT; Brousseau KP; Noon GP; Whisennand HH; Debakey ME; Nelson DL
Am Rev Respir Dis; 1989 Sep; 140(3):789-96. PubMed ID: 2506785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
